$85.90
-1.85[-2.11%]
At close: Apr 24
$85.90
0[0.00%]
After Hours: 4:19PM EDT
Edwards Lifesciences
(NYSE:EW)Latest News for Edwards Lifesciences Stock (NYSE:EW)
Edwards Lifesciences Stock (NYSE: EW)
Categories: All
Thursday, April 18, 2024
Wednesday, April 17, 2024
Monday, April 15, 2024
Friday, April 12, 2024
Thursday, April 11, 2024
Thursday, April 04, 2024
Wednesday, April 03, 2024
Tuesday, April 02, 2024
Tuesday, March 26, 2024
Friday, March 22, 2024
Thursday, March 21, 2024
Monday, March 18, 2024
Thursday, March 14, 2024
Thursday, March 07, 2024
- Edwards Lifesciences shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy.Benzinga Newsdesk - Mar 7, 2024, 10:17AM
- What 9 Analyst Ratings Have To Say About Edwards LifesciencesBenzinga Insights - Mar 7, 2024, 7:00AM
- B of A Securities Upgrades Edwards Lifesciences to BuyBenzinga Newsdesk - Mar 7, 2024, 6:14AM
Tuesday, February 27, 2024
Thursday, February 22, 2024
Friday, February 16, 2024
Monday, February 12, 2024
Wednesday, February 07, 2024
- Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $95Benzinga Newsdesk - Feb 7, 2024, 3:01PM
- These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 ResultsAvi Kapoor - Feb 7, 2024, 12:30PM
- RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $95Benzinga Newsdesk - Feb 7, 2024, 12:06PM
- Mizuho Maintains Buy on Edwards Lifesciences, Raises Price Target to $95Benzinga Newsdesk - Feb 7, 2024, 8:43AM
Tuesday, February 06, 2024
- Edwards Lifesciences shares are trading lower. The company reported Q4 financial results and issued Q1 and FY24 guidance.Benzinga Newsdesk - Feb 6, 2024, 4:27PM
- Edwards Lifesciences Sees FY24 Adj. EPS $2.70-$2.80 Vs $2.76 Est; Revenue $6.6B Vs $6.481B Est.Benzinga Newsdesk - Feb 6, 2024, 4:19PM
- Edwards Lifesciences Sees Q1 2024 Adj. EPS $0.62-$0.66 Vs $0.66 Est.; Revenue $1.61B Vs $1.562B Est.Benzinga Newsdesk - Feb 6, 2024, 4:18PM
- Edwards Lifesciences Q4 2023 Adj EPS $0.64, Inline, Sales $1.53B Beat $1.50B EstimateBenzinga Newsdesk - Feb 6, 2024, 4:16PM
- Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?Piero Cingari - Feb 6, 2024, 2:24PM
- US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This IndicatorShanthi Rexaline - Feb 6, 2024, 7:37AM
- Earnings Scheduled For February 6, 2024Benzinga Insights - Feb 6, 2024, 5:42AM
Monday, February 05, 2024
Friday, February 02, 2024
- Edwards Lifesciences shares are trading higher after the company announced its EVOQUE valve replacement system receive FDA approval for tricuspid valve. Also, Wells Fargo upgraded the stock from Equal-Weight to Overweight and announced a $94 price target.Benzinga Newsdesk - Feb 2, 2024, 11:24AM
- Expert Ratings For Edwards LifesciencesBenzinga Insights - Feb 2, 2024, 11:00AM
- Wells Fargo Upgrades Edwards Lifesciences to Overweight, Announces $94 Price TargetBenzinga Newsdesk - Feb 2, 2024, 10:49AM
- Edwards' EVOQUE Valve Replacement System Receives FDA Approval For Tricuspid RegurgitationBenzinga Newsdesk - Feb 2, 2024, 7:03AM